Unknown

Dataset Information

0

Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.

ABSTRACT: Chagas and COVID-19 are diseases caused by Trypanosoma cruzi and SARS-CoV-2, respectively. These diseases present very different etiological agents despite showing similarities such as susceptibility/risk factors, pathogen-associated molecular patterns (PAMPs), recognition of glycosaminoglycans, inflammation, vascular leakage hypercoagulability, microthrombosis, and endotheliopathy; all of which suggest, in part, treatments with similar principles. Here, both diseases are compared, focusing mainly on the characteristics related to dysregulated immunothrombosis. Given the in-depth investigation of molecules and mechanisms related to microthrombosis in COVID-19, it is necessary to reconsider a prompt treatment of Chagas disease with oral anticoagulants.

SUBMITTER: Perez-Campos Mayoral L 

PROVIDER: S-EPMC8190527 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Chagas and COVID-19 are diseases caused by Trypanosoma cruzi and SARS-CoV-2, respectively. These diseases present very different etiological agents despite showing similarities such as susceptibility/risk factors, pathogen-associated molecular patterns (PAMPs), recognition of glycosaminoglycans, inflammation, vascular leakage hypercoagulability, microthrombosis, and endotheliopathy; all of which suggest, in part, treatments with similar principles. Here, both diseases are compared, focusing main  ...[more]

Similar Datasets

Unknown Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
| S-EPMC7497892 | biostudies-literature
Transcriptomics Genome-wide PBMCs Profiling Reveals Early Detection of Immunothrombotic Dysregulation in COVID-19 based on Blood Routine Test: A Multi-Center Retrospective Study of 1219 Patients
2021-10-06 | GSE167930 | GEO
Unknown DNA Methylation Changes in COVID-19 Link to Long-Term Transcriptional Dysregulation in Airway Cells
| S-SCDT-10_1038-S44321-025-00215-5 | biostudies-other
Genomics covid-19 study
| PRJEB43387 | ENA
Unknown Anticoagulation in COVID-19.
| S-EPMC8673870 | biostudies-literature
Unknown Anticoagulation in COVID-19: a single-center retrospective study.
| S-EPMC7850331 | biostudies-literature
Genomics Test COVID-19 Study
| PRJEB38185 | ENA
Unknown Anticoagulation in COVID - 19: An Update.
| S-EPMC7648443 | biostudies-literature
Transcriptomics COVID-19 Vaccine Immune Responses Study (COVIRS)
2023-01-12 | GSE199750 | GEO
Unknown Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease.
| S-EPMC8668393 | biostudies-literature